通过对动脉样硬化症的权重基因共同表达网络分析确定了新的生物标志物
Jiajun Ni1,2, Kaijian Huang2, Jialin Xu3
1Clinical Medicine-Internal Medicine, School of Medicine of Nantong University, Nantong University, No. 19 Qixiu Road, 22600, Nantong City, Jiangsu Province, China.
Herz
|September 18, 2023
概括
这项研究确定了包括TYROBP和CD14在内的四个关键基因,作为动脉样硬化 (AS) 的潜在诊断生物标志物. 这些发现可能有助于改善AS的临床诊断.
科学领域:
- 基因组学就是基因组学.
- 生物标志物发现发现
- 心血管研究研究心血管研究
背景情况:
- 动脉样硬化 (AS) 是一个重大的健康挑战.
- 确定可靠的AS诊断生物标志物对于早期检测和管理至关重要.
研究的目的:
- 查动脉样硬化 (AS) 的潜在诊断生物标志物.
- 确定与AS发展和进展相关的关键基因.
主要方法:
- 利用了基因表达总量 (GEO) 数据库中的基因表达特征.
- 应用差异基因表达分析和加权基因共表达网络分析 (WGCNA).
- 进行了基因本体学 (GO),KEGG通路和蛋白质-蛋白质相互作用 (PPI) 网络分析. 分析了免疫细胞透的情况.
主要成果:
- 在两个数据集中确定了40个与AS发生相关的重叠基因.
- 突出了十个网络枢纽基因,包括TYROBP,CSF1R和CD14.
- 验证了TYROBP,CSF1R,FCGR1B和CD14作为AS的潜在诊断生物标志物.
- 发现TYROBP和免疫细胞透之间存在强烈的相关性.
结论:
- 四个基因 (TYROBP,CSF1R,FCGR1B和CD14) 被确定为AS的潜在有效生物标志物.
- 这些生物标志物可能有助于指导动脉样硬化的临床诊断.
相关概念视频
Genome-wide Association Studies-GWAS
13.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.6K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
200
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
200
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
13
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
13
Atherosclerosis I: Introduction
9
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
9


